Connect with us

Press Releases

Nordic Group B.V. Appoints Renowned Oculoplastic Surgeon, John P. Fezza, MD to Its Medical Advisory Board

They did this through its subsidiary Nordic Pharma, Inc. (U.S.)




(PRESS RELEASE) BERWYN, PA – Nordic Pharma, Inc., a subsidiary of Nordic Group B.V. announced today that eminent oculoplastic surgeon John P. Fezza, MD will serve on its U.S. Medical Advisory Board (MAB) which includes Eric Donnenfeld, MD (New York), Richard Lindstrom, MD (Minnesota),
Vance Thompson, MD (South Dakota), Preeya Gupta, MD (North Carolina), Paul Karpecki, OD (Kentucky), Lisa Nijm, MD, JD (Illinois), and Selina McGee, OD (Oklahoma).

Dr. Fezza joins the MAB as Nordic Pharma prepares to launch a novel therapy for Dry Eye Disease, LACRIFILL® Canalicular Gel. The FDA-cleared, cross-linked hyaluronic acid derivative LACRIFILL is intended to temporarily block tear drainage by the occlusion of the canalicular system.

“The entire U.S. Medical Advisory Board of Nordic Pharma is honored and delighted to welcome John Fezza, MD, a world class oculoplastic surgeon to our MAB” said Eric Donnenfeld, MD, MAB Chair. “John will bring his unique perspective and understanding of the lacrimal drainage system to LACRIFILL’s novel treatment of dry eye disease.”

“I am thrilled to join this incredible Medical Advisory Board comprised of some of the most esteemed leaders in eyecare” said John Fezza, MD. “They share a common vision of improving patient care, and understand the importance of treating dry eye disease. As the inventor of LACRIFILL Canalicular Gel, I believe we are launching a novel product that will change our approach to treating dry eyes.”

Nordic Pharma’s U.S. Medical Advisory Board brings together leading eye care providers from across the country, including ophthalmologists and optometrists in private practice and affiliated with major health systems. “John’s addition to our U.S. Medical Advisory Board provides historical and unique insights to this stellar group of optometry and ophthalmology leaders that will help set us up for a successful launch of LACRIFILL Canalicular Gel later this year” said Philip Gioia, President of the U.S. team that will launch LACRIFILL under the Nordic Pharma brand.

Nordic Pharma is committed to engaging ophthalmologists and optometrists in the early launch stages of LACRIFILL Canalicular Gel. As part of the approach, members of the LACRIFILL team will be attending Vision Expo East, 2024 to share the benefits of LACRIFILL Canalicular Gel with optometrists and to discuss select pre-order opportunities.


“Optometry plays a crucial role in the management of dry eye disease as evident by prescribing the majority of medications to performing procedures like punctal occlusion” said Paul M. Karpecki, O.D., FAAO. “The support for the profession shown by Nordic Pharma and the launch of the innovative product LACRIFILL Canalicular Gel, will go far in helping millions of patients suffering from dry eye disease.”

In addition to Dr. Fezza’s appointment, the LACRIFILL launch is further benefitting from Todd Love being hired as National Sales Director by Inizio Engage. “Todd comes to us with a strong legacy of leadership and camaraderie in the eye care industry for nearly 25 years” said Jai G. Parekh, MD, MBA, Chief Commercial Officer of Nordic Pharma Eye Care U.S. “He is a ‘true natural’ and after years of experience at Alcon, Bausch & Lomb, and more recently, Sight Sciences, we look to him to help lead our initiatives in the field with our esteemed sales force. His acumen will be critical to our launch of LACRIFILL Canalicular Gel within the eye care community; I look forward to working closely with him.”



The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines






Get the most important news and business ideas for eyecare professionals every weekday from INVISION.


Most Popular